IDH2 and central nervous system cancer: Downregulation of PDL‐1 in IDH‐mutant glioma was first described in 2016 by Wang et al., which analyzed transcriptomic data of 976 glioma samples of grades II–IV, including 301 microarray data from the CGGA project and 675 RNA‐seq data from TCGA.